Clinical Trials Directory

Trials / Completed

CompletedNCT03483597

The Survey of Satisfaction in Chinese Rheumatologists and Patients With Rheumatoid Arthritis

Status
Completed
Phase
Study type
Observational
Enrollment
1,365 (actual)
Sponsor
Chinese SLE Treatment And Research Group · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

A questionnaire for this research is designed, which initiated from TSQM-II treatment satisfaction questionnaire and based on research launched by rheumatology and immunology departments of Chinese 12 public tertiary hospitals distributed directionally by Chinese Rheumatism Data Center (CRDC). The research is about treatment satisfaction and its influencing factors for Chinese rheumatoid immunologists and rheumatoid arthritis (RA) patients as well as their expectations for treating this disease. This research will explore the matching degree between treatment satisfaction and expectation about rheumatoid arthritis from doctors and patients.

Detailed description

In the last decade, China has made quick progress on treatment of rheumatoid arthritis. However, the improvement of remission rate cannot fully represent needs of patients for health. To meet health demands of patients and improve their satisfaction, an efficacy evaluation system based on the outcome report of patients should be established. A questionnaire for this research is designed and mended in view of TSQM-II treatment satisfaction questionnaire and the actual situation of RA diagnosis and treatment in China. An investigation on treatment satisfaction and its influencing factors for Chinese rheumatoid immunologists and rheumatoid arthritis (RA) patients as well as their expectations for this disease is carried out based on 120 rheumatoid immunologists and 1,200 rheumatoid arthritis patients (1:10) from Chinese 12 public tertiary hospitals distributed directionally by Chinese Rheumatism Data Center (CRDC). The research concludes rheumatoid specialist physicians for doctor population, and persons aged over 18 for patient population who has been confirmed as RA for 6 months above, excluding patients with Chinese reading comprehension barriers or without any RA treatment. Finally, summarize and analyze the total score of satisfaction from doctors and patients, average score of doctors and patients for various medical demands, as well as the satisfaction of patients about communication and service during medical treatment.

Conditions

Interventions

TypeNameDescription
OTHERTSQM-IITreatment Satisfaction Questionnaire for Medication (TSQM Version II) will be used in all groups

Timeline

Start date
2018-03-31
Primary completion
2018-04-30
Completion
2018-04-30
First posted
2018-03-30
Last updated
2023-08-31

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03483597. Inclusion in this directory is not an endorsement.